Active Job Posts In This Industry

  • Fusion Pharmaceuticals

    2024-05-06 · Hamilton · Full Time · Permanent · Fusion Pharmaceuticals (NASDAQ: FUSN) is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines. Fusion connects alpha particle emitting isotopes to various targeting molecules to selectively deliver the alpha emitting payloads to tumors. Fusion’s clinical portfolio includes: FPI-2265 targeting prostate specific membrane antigen (PSMA) for metastatic castration

    Go to Job Post Save Job Post Share

  • AtomVie Global Radiopharma Inc.

    2024-05-03 · Hamilton · Full Time · Permanent · Professional occupations in business management consulting · AtomVie Global Radiopharma Inc. is a global leading GMP manufacturer and distributer of clinical and commercial radiopharmaceuticals. We work with our partners to transform patients’ lives by advancing high quality drugs for the treatment and diagnosis of diseases. We are a community that challenges ourselves professionally, takes pride in what

    Go to Job Post Save Job Post Share

  • AtomVie Global Radiopharma Inc.

    2024-05-03 · Hamilton · Full Time · Permanent · AtomVie Global Radiopharma Inc. (AtomVie) a global leading GMP manufacturer and distributor of clinical and commercial radiopharmaceuticals, is gearing up to launch its new state-of-the-art manufacturing facility. We work with our partners to transform patients’ lives by advancing high quality drugs for the treatment and diagnosis of diseases. We are

    Go to Job Post Save Job Post Share

  • Fusion Pharmaceuticals

    This job is in demand.

    2024-05-02 · Hamilton · Full Time · Permanent · Industrial engineering and manufacturing technologists and technicians · Fusion Pharmaceuticals (NASDAQ: FUSN) is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines. Fusion connects alpha particle emitting isotopes to various targeting molecules to selectively deliver the alpha emitting payloads to tumors. Fusion’s clinical portfolio includes: FPI-2265 targeting prostate specific membrane antigen (PSMA) for metastatic castration

    Go to Job Post Save Job Post Share

  • Centre for Probe Development and Commercialization

    2024-04-30 · Hamilton · Full Time · Permanent · Professional occupations in business management consulting · AtomVie Global Radiopharma Inc. is a global leading GMP manufacturer and distributer of clinical and commercial radiopharmaceuticals. We work with our partners to transform patients’ lives by advancing high quality drugs for the treatment and diagnosis of diseases. We are a community that challenges ourselves professionally, takes pride in what

    Go to Job Post Save Job Post Share

  • AtomVie Global Radiopharma Inc.

    2024-04-24 · Hamilton · Full Time · Contract · AtomVie Global Radiopharma Inc. is a global leading GMP manufacturer and distributer of clinical and commercial radiopharmaceuticals. We work with our partners to transform patients’ lives by advancing high quality drugs for the treatment and diagnosis of diseases. We are a community that challenges ourselves professionally, takes pride in what

    Go to Job Post Save Job Post Share

  • Centre for Probe Development and Commercialization

    2024-04-24 · Hamilton · Full Time · Permanent · AtomVie Global Radiopharma Inc. (AtomVie) a global leading GMP manufacturer and distributor of clinical and commercial radiopharmaceuticals, is gearing up to launch its new state-of-the-art manufacturing facility. We work with our partners to transform patients’ lives by advancing high quality drugs for the treatment and diagnosis of diseases. We are

    Go to Job Post Save Job Post Share

  • Centre for Probe Development and Commercialization

    This job is in demand.

    2024-04-08 · Hamilton · Full Time · Permanent · Other labourers in processing, manufacturing and utilities · AtomVie Global Radiopharma Inc. is a global leading GMP manufacturer and distributer of clinical and commercial radiopharmaceuticals. We work with our partners to transform patients’ lives by advancing high quality drugs for the treatment and diagnosis of diseases. We are a community that challenges ourselves professionally, takes pride in what

    Go to Job Post Save Job Post Share

  • AtomVie Global Radiopharma Inc.

    2024-03-28 · Hamilton · Full Time · Contract · Chemists · AtomVie Global Radiopharma Inc. is a global leading GMP manufacturer and distributer of clinical and commercial radiopharmaceuticals. We work with our partners to transform patients’ lives by advancing high quality drugs for the treatment and diagnosis of diseases. We are a community that challenges ourselves professionally, takes pride in what

    Go to Job Post Save Job Post Share

  • Fusion Pharmaceuticals

    2024-03-05 · Hamilton · Full Time · Permanent · Fusion Pharmaceuticals (NASDAQ: FUSN) is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines. Fusion connects alpha particle emitting isotopes to various targeting molecules to selectively deliver the alpha emitting payloads to tumors. Fusion’s clinical portfolio includes: FPI-2265 targeting prostate specific membrane antigen (PSMA) for metastatic castration

    Go to Job Post Save Job Post Share

  • AtomVie Global Radiopharma Inc.

    2024-03-04 · Hamilton · Full Time · Permanent · Contractors and supervisors, machining, metal forming, shaping and erecting trades and related occupations · AtomVie Global Radiopharma Inc. is a global leading GMP manufacturer and distributer of clinical and commercial radiopharmaceuticals. We work with our partners to transform patients’ lives by advancing high quality drugs for the treatment and diagnosis of diseases. We are a community that challenges ourselves professionally, takes pride in what

    Go to Job Post Save Job Post Share

  • Fusion Pharmaceuticals

    2024-02-27 · Hamilton · Full Time · Permanent · Fusion Pharmaceuticals (NASDAQ: FUSN) is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines. Fusion connects alpha particle emitting isotopes to various targeting molecules to selectively deliver the alpha emitting payloads to tumors. Fusion's clinical portfolio includes: FPI-2265 targeting prostate specific membrane antigen (PSMA) for metastatic castration

    Go to Job Post Save Job Post Share

Help Us Serve You Better

We are collecting data to better understand who is looking for work and what kind of opportunities jobseekers are searching for. This data is completely anonymous and non-personally identifiable.

Your Age: